Oramed Pharmaceuticals announces annual shareholder meeting
Reuters2026/08/03 20:07- Oramed will hold its 2026 annual stockholders meeting in Jerusalem on Sept. 15, 2026.
- Vote scheduled on electing six directors, including Nadav Kidron, Miriam Kidron, Arie Mayer, Yehuda Reznick, Benjamin Shapiro, Daniel Aghion.
- Shareholders will also vote on ratifying Kesselman & Kesselman as independent auditor for the year ending Dec. 31, 2026.
- Ballot includes a plan to raise the 2019 long-term incentive plan share pool by 3,000,000 to 12,500,000 shares.
- Additional items include advisory votes on executive pay, the frequency of future pay votes, and a proposal to adjourn the meeting if needed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Fitch "shows mercy" and maintains France's A+ rating, but warns that uncontrolled deficits could lead to a downgrade
Fitch Ratings recently announced that it is maintaining France's sovereign credit rating at "A+" with a "stable" outlook, even though the agency has once again warned that sustained fiscal deficits and rising public debt amidst increasing political uncertainty could still trigger a future rating downgrade.
Here’s Why XRP Price Just Crashed Sharply
What Can We Expect from Bitcoin (BTC) and Dogecoin (DOGE) Prices in the Coming Days?
BTC Recovers From Sub-$77K Dip, XRP Drops Below $1.40: Weekend Watch
Crypto prices
More
